Atlas datasets generated by the HTAN Research Centers and pilot projects will be made available to the public via scheduled releases that we expect to begin in late 2019 or 2020. Detailed information about upcoming data releases will be provided here once it is available.

In anticipation of our first data release, the tables below summarize the types of experimental data being generated by each of the atlas teams across the specified tissue and tumor types and patient populations.

Figure 4. Key Tumors Studied by the Consortium HTAN centers will generate 3D atlases of human tumors spanning different tissue types across adult and pediatric tumors from patients with pre-cancer, primary tumors, and metastases, as well as resistant tumors before and after treatment. Projected ranges for the number of samples to be profiled over the 5-year HTAN period are depicted for each center and tumor type. In some cases, multiple samples will be profiled from the same patient. HTAN includes the following centers: Children’s Hospital of Philadelphia (CHOP), Dana-Farber Cancer Institute (DFCI), Oregon Health & Science University (OHSU), Washington University in St. Louis (WUSTL), Duke University School of Medicine, Pre-Cancer Atlas Pilot Project (PCAPP), Human Tumor Pilot Project (HTAPP), Vanderbilt University Medical Center (VUMC), Stanford University, Boston University (BU), Memorial Sloan Kettering Cancer Center (MSCKK), and Harvard Medical School (HMS).